{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T02:32:47Z","timestamp":1773628367530,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.vaccine.2008.05.023","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T15:45:33Z","timestamp":1212507933000},"page":"4041-4047","source":"Crossref","is-referenced-by-count":22,"title":["Domain specificity of the human antibody response to Bacillus anthracis protective antigen"],"prefix":"10.1016","volume":"26","author":[{"given":"Donald C.","family":"Reason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuska","family":"Ullal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Liberato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Keitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6860","key":"10.1016\/j.vaccine.2008.05.023_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.023_bib2","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6619","key":"10.1016\/j.vaccine.2008.05.023_bib3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"issue":"7002","key":"10.1016\/j.vaccine.2008.05.023_bib4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.vaccine.2008.05.023_bib5","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.023_bib6","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1073\/pnas.062160399","article-title":"Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen","volume":"99","author":"Cunningham","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.023_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1006\/bbrc.2001.5613","article-title":"Hydrophobic residues Phe552, Phe554, Ile562, Leu566, and Ile574 are required for oligomerization of anthrax protective antigen","volume":"287","author":"Ahuja","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.023_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.molimm.2007.06.159","article-title":"Paratope diversity in the human antibody response to Bacillus anthracis protective antigen","volume":"45","author":"Zhou","year":"2008","journal-title":"Mol Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.05.023_bib9","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect Immun"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2008.05.023_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","article-title":"Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies","volume":"142","author":"Little","year":"1996","journal-title":"Microbiology"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.023_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1574-695X.2006.00114.x","article-title":"Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen","volume":"47","author":"Gubbins","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.023_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/IAI.65.1.261-266.1997","article-title":"Human Fab fragments specific for the Haemophilus influenzae b polysaccharide isolated from a bacteriophage combinatorial library use variable region gene combinations and express an idiotype that mirrors in vivo expression","volume":"65","author":"Reason","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.05.023_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1745-6150-1-24","article-title":"Codon insertion and deletion functions as a somatic diversification mechanism in human antibody repertoires","volume":"1","author":"Reason","year":"2006","journal-title":"Biol Direct"},{"issue":"8","key":"10.1016\/j.vaccine.2008.05.023_bib14","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/IAI.70.8.4083-4091.2002","article-title":"Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F","volume":"70","author":"Zhou","year":"2002","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.023_bib15","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/IAI.72.6.3505-3514.2004","article-title":"Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 6B","volume":"72","author":"Zhou","year":"2004","journal-title":"Infect Immun"},{"issue":"17","key":"10.1016\/j.vaccine.2008.05.023_bib16","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.023_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.molimm.2003.09.006","article-title":"IMGT-ONTOLOGY and IMGT databases, tools and Web resources for immunogenetics and immunoinformatics","volume":"40","author":"Lefranc","year":"2004","journal-title":"Mol Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.023_bib18","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1084\/jem.188.11.2151","article-title":"The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus","volume":"188","author":"Matsuda","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.05.023_bib19","series-title":"Sequences of proteins of immunological interest","author":"Kabat","year":"1991"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.023_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CDLI.11.5.919-923.2004","article-title":"Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum","volume":"11","author":"Semenova","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2008.05.023_bib21","unstructured":"Anthrax Vaccine Adsorbed (Biothrax\u2122) Package Insert; 2002."},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.023_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI0216204","article-title":"Development of an improved vaccine for anthrax","volume":"110","author":"Leppla","year":"2002","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.023_bib23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","article-title":"Protective immunity induced by Bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.023_bib24","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2008.05.023_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.023_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.023_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system: immune sequelae","volume":"87","author":"Williamson","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2008.05.023_bib28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.023_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","article-title":"Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"52","author":"Turnbull","year":"1986","journal-title":"Infect Immun"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2008.05.023_bib30","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2008.05.023_bib31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.023_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pds.712","article-title":"Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the vaccine adverse event reporting system (VAERS)","volume":"11","author":"Sever","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.023_bib33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1085","article-title":"An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program","volume":"14","author":"Martin","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.023_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/pds.936","article-title":"Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the vaccine adverse event reporting system (VAERS)","volume":"13","author":"Sever","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"33\u201334","key":"10.1016\/j.vaccine.2008.05.023_bib35","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.023_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14760584.5.4.417","article-title":"Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine","volume":"5","author":"Keitel","year":"2006","journal-title":"Expert Rev Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.023_bib37","unstructured":"Zhou J, Ullal A, Liberato J, Sun J, Keitel W, Reason DC. Frequency and distribution of neutralizing paratopes in the human immune response to the protective antigen of Bacillus anthracis; in preparation."},{"issue":"32","key":"10.1016\/j.vaccine.2008.05.023_bib38","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.1016\/S0021-9258(17)32036-7","article-title":"Anthrax protective antigen forms oligomers during intoxication of mammalian cells","volume":"269","author":"Milne","year":"1994","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.023_bib39","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.4049\/jimmunol.176.10.6155","article-title":"Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production","volume":"176","author":"Fang","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.05.023_bib40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.iy.09.040191.003423","article-title":"The cell biology of antigen processing and presentation","volume":"9","author":"Brodsky","year":"1991","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.023_bib41","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1128\/IAI.00719-07","article-title":"Anthrax protective antigen cleavage and clearance from the blood of mice and rats","volume":"75","author":"Moayeri","year":"2007","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T14:49:21Z","timestamp":1631371761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08005951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":41,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0264410X08005951"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}